Jaguar Health (JAGX) Capital Expenditures (2014 - 2026)

Jaguar Health (JAGX) has 12 years of Capital Expenditures data on file, last reported at -$37000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures changed N/A year-over-year to -$37000.0 in Q1 2026; TTM through Mar 2026 was -$1.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$1.2 million, down 7431.25% from the prior year.
• Capital Expenditures for Q1 2026 stood at -$37000.0, up from -$1.2 million in the prior quarter.
• Over the last five years, Capital Expenditures for JAGX reached as high as $1.2 million in Q2 2022 and fell as low as -$1.3 million in Q4 2022.
• Historically, Capital Expenditures has averaged -$66266.7 across 5 years, with a median of $4000.0 in 2023.
• On a YoY basis, Capital Expenditures climbed as much as 37650.0% in 2024 and fell as far as 10400.0% in 2024.
• Year by year, Capital Expenditures stood at -$1.3 million in 2022, then surged by 99.77% to -$3000.0 in 2023, then plunged by 10400.0% to -$315000.0 in 2024, then slumped by 289.52% to -$1.2 million in 2025, then jumped by 96.98% to -$37000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were -$37000.0 in Q1 2026, -$1.2 million in Q4 2025, and $160000.0 in Q3 2025.